Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nautilus Biotechnology, Inc. - Common Stock (NQ:NAUT)

1.433 +0.023 (+1.61%)
Streaming Delayed Price Updated: 9:33 AM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nautilus Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Nautilus (NAUT) Q3 2025 Earnings Call Transcript
Nautilus (NAUT) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Nautilus Biotechnology Reports Third Quarter 2025 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Earnings Scheduled For October 28, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
What's going on in today's session
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. 
Via Chartmill
Earnings Scheduled For July 31, 2025
 
Via Benzinga
Earnings Scheduled For April 29, 2025
 
Via Benzinga
Earnings Scheduled For February 27, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
Via ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Reports Second Quarter 2025 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025
From Nautilus Biotechnology Inc.
Via GlobeNewswire
These stocks are moving in today's pre-market session
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Reports First Quarter 2025 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
Dr. Mallick to be inducted into the Academy for Radiology and Biomedical Imaging Research’s esteemed Council of Distinguished Investigators for his outstanding contributions to medical imaging 
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Reports Third Quarter 2024 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer
Industry veteran brings multidisciplinary expertise leading Mass Spectrometry division at Agilent Technologies to a company building a platform to power next-generation proteomics 
From Nautilus Biotechnology Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.